Flemban Arwa F, Kabrah Saeed, Alahmadi Hanaa, Alqurashi Raghad K, Turaes Anwar S, Almaghrabi Ruba, Al Harbi Samah, Khogeer Asim A
Pathology Department, Faculty of Medicine, Umm Al-Qura University, P.O. Box 50199, Makkah 21955, Saudi Arabia.
Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, P.O. Box 50199, Makkah 21955, Saudi Arabia.
Diagnostics (Basel). 2022 Nov 7;12(11):2716. doi: 10.3390/diagnostics12112716.
Thyroid cancer is the most prevalent endocrine cancer among the female population in the Kingdom of Saudi Arabia (KSA) and the ninth most common in the male population in Saudi Arabia. Over the past years, an increasing incidence of thyroid cancer has been reported in Saudi Arabia. However, the etiology of thyroid cancer is still not clear. Therefore, this study aimed to estimate thyroid cancer incidence and mortality trends in Saudi Arabia from 1990 to 2019. The current study utilized the Global Burden of Disease and the Institute for Health Metrics and Evaluation databases to extract prevalence data of thyroid cancer in Saudi Arabia from 1990 to 2019. Moreover, the current project utilizes Global Burden of Disease (GBD) web-based tools to visualize these data. In total, 23,846 cases (17,220 females and 6626 males) were diagnosed with thyroid cancer in Saudi Arabia from 1990 to 2019. The incidence is higher in females than in males. Over these 30 years, women's incidence steadily increased by 15-fold versus a 22-fold increase in men. Moreover, there were 2056 deaths in total caused by thyroid cancer in KSA. The mortality rate in women steadily increased by threefold in the same period. However, the increase in mortality was higher in males (sixfold). A high percentage of YLLs was observed in males, with around 24.8% ranging from 30 to 34 and 40 to 45 years. Thyroid cancer incidence rates have increased exponentially between 1990 and 2019. The expansion of the incidence of thyroid cancer in Saudi Arabia could be due to the increased development in detection and diagnosis. The current study provided evidence of the need to increase awareness and diagnosis in the male population.
甲状腺癌是沙特阿拉伯王国女性人群中最常见的内分泌癌，在沙特男性人群中则是第九大常见癌症。在过去几年里，沙特阿拉伯报告的甲状腺癌发病率呈上升趋势。然而，甲状腺癌的病因仍不明确。因此，本研究旨在估算1990年至2019年沙特阿拉伯甲状腺癌的发病率和死亡率趋势。本研究利用全球疾病负担和健康指标与评估研究所的数据库，提取1990年至2019年沙特阿拉伯甲状腺癌的患病率数据。此外，本项目利用基于网络的全球疾病负担（GBD）工具来可视化这些数据。1990年至2019年期间，沙特阿拉伯共有23846例甲状腺癌确诊病例（女性17220例，男性6626例）。女性的发病率高于男性。在这30年中，女性发病率稳步上升了15倍，而男性则上升了22倍。此外，沙特阿拉伯共有2056人死于甲状腺癌。同期女性死亡率稳步上升了两倍。然而，男性死亡率上升幅度更大（六倍）。在男性中观察到较高比例的寿命损失年数，在30至34岁和40至45岁年龄段约为24.8%。1990年至2019年期间，甲状腺癌发病率呈指数增长。沙特阿拉伯甲状腺癌发病率的上升可能是由于检测和诊断技术的发展。本研究提供了证据，表明有必要提高男性人群的认识和诊断水平。
